Sedia Biosciences Corporation, founded in 2009 and based in Beaverton, Oregon, is a privately held medical device and diagnostics company. Its core mission is to advance global healthcare access by developing innovative disease surveillance and monitoring tools, expanding point-of-care diagnostic testing into both technology-rich and resource-limited settings, and providing cost-effective specimen collection devices. Sedia's products and services focus on professional analytic and diagnostic solutions for the medical field.
Notable affiliated individuals and investors include industry experts in medical diagnostics and healthcare innovation. The company has achieved significant milestones in making diagnostic tools more accessible globally, particularly in underserved regions. Sedia Biosciences' impact is marked by its commitment to improving healthcare delivery through cost-effective and innovative diagnostic solutions, contributing to better disease management and patient outcomes worldwide.
